Completed NA INTERVENTIONAL 1-arm NCT04873544

Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach

Sponsor: Nanjing First Hospital, Nanjing Medical University

Updated 3 times since 2021 Last updated: May 5, 2021 Started: Oct 1, 2018 Primary completion: Jun 30, 2019 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04873544, this NA trial focuses on ERAS and Knee Osteoarthritis and remains completed. Sponsored by Nanjing First Hospital, Nanjing Medical University, it has been updated 3 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanjing First Hospital, Nanjing Medical University

Data source: Nanjing First Hospital, Nanjing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China